The pharmaceutical and healthcare industries have all been disrupted by COVID-19. Uncertainty prevails and the industry is in urgent need for new direction.
Delivered digitally, the 7th Pharmacon Asia event has been recast to be the first event of its kind to enable a post COVID industry with practical and strategic solutions.
Repurposed to address the emerging and likely permanent shifts in the pharma and life sciences industry, this is the go-to event to access practical and strategic content from leaders across China, Taiwan, Korea, Japan, Singapore, Australia, and more. Immediate COVID related solutions will be balanced with a longer-term industry outlook against the entire drug landscape.